Trial Search Results

Prediction of Jaundice in Term Infants

The objective of this study was to describe total bilirubin production in healthy term infants as a means of understanding the differences in jaundice pigment production associated with various common clinical circumstances.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

NICHD Neonatal Research Network

Stanford Investigator(s):

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Infants born via cesarean delivery (to ensure subjects would still be hospitalized and
   available for ETCOc measurement and blood sampling on day 3 postpartum)

   - Delivery within each center's scheduled recruitment period (to maximize nursing
   availability and minimize cost)

   - Birth weight >2500 g

   - Gestational age >37 weeks

Exclusion Criteria:

   - Any illness that would require admission to the neonatal intensive-care unit (NICU)
   within 8 hours of birth

Ages Eligible for Study

N/A - 8 Hours

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting